Item 7.01.Regulation FD Disclosure.

Representatives of NeuroBo Pharmaceuticals, Inc. will be presenting the slides attached as Exhibit 99.1 to this report at the H.C. Wainwright BIOCONNECT 2021 Conference, which is scheduled to take place from January 11-14, 2021.

The information furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01.Financial Statements and Exhibits.



(d)Exhibits


Exhibit
  No.                        Description

99.1         Company Presentation, dated January 8, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses